Title |
Proteomics progresses in microbial physiology and clinical antimicrobial therapy
|
---|---|
Published in |
European Journal of Clinical Microbiology & Infectious Diseases, November 2016
|
DOI | 10.1007/s10096-016-2816-4 |
Pubmed ID | |
Authors |
B. Chen, D. Zhang, X. Wang, W. Ma, S. Deng, P. Zhang, H. Zhu, N. Xu, S. Liang |
Abstract |
Clinical microbial identification plays an important role in optimizing the management of infectious diseases and provides diagnostic and therapeutic support for clinical management. Microbial proteomic research is aimed at identifying proteins associated with microbial activity, which has facilitated the discovery of microbial physiology changes and host-pathogen interactions during bacterial infection and antimicrobial therapy. Here, we summarize proteomic-driven progresses of host-microbial pathogen interactions at multiple levels, mass spectrometry-based microbial proteome identification for clinical diagnosis, and antimicrobial therapy. Proteomic technique progresses pave new ways towards effective prevention and drug discovery for microbial-induced infectious diseases. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 48 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 7 | 15% |
Student > Bachelor | 7 | 15% |
Researcher | 6 | 13% |
Student > Ph. D. Student | 5 | 10% |
Student > Postgraduate | 4 | 8% |
Other | 9 | 19% |
Unknown | 10 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 14 | 29% |
Immunology and Microbiology | 5 | 10% |
Agricultural and Biological Sciences | 5 | 10% |
Engineering | 4 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 4% |
Other | 6 | 13% |
Unknown | 12 | 25% |